2^nd Annual Congress on
Microbiology and Microbiologists

Ziad A.ElNasser completed his Ph.D. in Pathology and Microbiology from Brigham Young University, 1986. He has completed Bsc. in Medicine and Surgery from University Of Jordan, 1980. Present he is Clinical Pathologist, (Clinical Microbiology) King Abdulla University Hospital, Adjunct Professor, Faculty of Health, York University, Toronto Canada, Director of CISEPO (Canadian International Science Exchange program, Jordan Branch) and Associate Professor of Clinical Microbiology, Faculty of Medicine, Jordan University of Science and Technology.

Pathology and Microbiology

Mamdouh Nassar was born in Cairo. He graduated a Bachelor's Degree from Biology (zoology, botany, and toxicology) Department, Faculty of Science, Cairo University. received his MSc Degree in from the same University. PhD degree (channel system) between University of Maryland College Park (USA) and Cairo University. He had many studies for field of sleeping sickness and malaria diseases of vectors stomoxys calcitrans and anopheles in USA Florida , jazan and jeda. staff member program (visitor exchange), University of Maryland College Park, USA. He is a professor of biological sciences at Cairo University, King Abd-Alziz, University Jazan and King Khalid Universities. He was worked at laboratory staff, for dietary microbiology at environmental system service, Beltsville, USA. He was also consultant advisor at Home care company and Al-nasr chemicals company.

Isolation and identification of natural bioactive compounds, Natural toxins, and Environmental Safety, Biosafety and chemical hazards, Toxins and Human health.

Dr. Nassiri is a former Associate Dean of Global Health at the Michigan State University (MSU). He also served as the MSU director of Institute of International Health. He is currently Professor of Clinical Pharmacology and Toxicology, Professor of Family and Community Medicine, and, lecturer in Global Health, Infectious Diseases and Tropical Medicine. He currently works on international public health issues relating to chronic diseases and has expertise in global health. He has made contributions in various fields of medical sciences including clinical investigation and health education. Based on his extensive experience and expertise in chronic infectious diseases including HIV/AIDS, as well as antimicrobial resistance and human gut microbiome, he had developed clinical research programs in Brazil, South Africa, Haiti, Dominican Republic and Mexico. He had served as editorial board member for the journal of HIV and AIDS Review. He is currently on editorial board member for AIDS Patient Care and STDs, J of AIDS Clin Res., and Int. J. of Global Health. Prof. Nassiri has delivered seminar presentations on Infectious Diseases, Tropical Medicine, HIV/AIDS, Global Health, antibiotic resistance, and public health interventions in numerous national and international conferences and conducted workshops on these topics. He is internationally recognized for his work in the areas of building effective international partnerships particularly in global health, community health, clinical care capacity building, and technical assistance mechanism. He is the founder of Michigan State University Osteopathic and Primary Health Clinic in Merida, Yucatan, Mexico. He has developed academic and research partnership programs with Federal University of Para Institute of Tropical Medicine in Belem, Brazil. In addition, he has served as scientific and organizing committee member for numerous international meetings and symposia. As for his current academic activities in medicine, he currently directs three online courses; Tropical Medicine, Pharmacotherapy of Infectious Diseases, and Management of Human Viral Infections.

Clinical Pharmacology of HIV/AIDS, Viral Pathogenesis, Antibiotic Resistance, Prevention and Control of Infectious Diseases, Tropical Medicine, Global health, and Community-based Public Health Interventions. In collaboration with his Brazilian colleagues, he conducts research in the eastern Brazilian Amazon population on incidence and prevalence of HIV, TB, Hepatitis C, HPV, as well as antimicrobial resistance.

Ahmed Hegazi is currently a Professor of Microbiology and Immunology in the National Research Center, Egypt. Prof. Hegazi received his master's degree in 1979, and his Ph.D. in 1981. Hegazi organized and contributed to national and international research projects since 1977 and up till now; he has been the principal investigator on multiple research projects within the National Research Center. He has published 226 scientific papers and articles in national and international journals. He also served on the board of multiple national and international scientific journals as well As also served on the organizer of multiple national and international scientific conferences.

Hegazi's research work has been focused lately on bee products and their therapeutic effects.

Giulio Tarro, graduated from Medicine School of Naples University. Research Associate at Division of Virology and Cancer Research, Children’s Hospital and Assistant Professor of Research Pediatrics, College of Medicine, Cincinnati, Ohio. He is a Professor of Oncological Virology at University of Naples. He worked for National Research Council, Rome, and for National Cancer Institute, Frederick Center, Maryland. He became Division Chief of Virology, and then Department Chief of Diagnostic Laboratories, D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006-. Since 2007 he is Chairman Committee on Biotechnologies and Virus Sphere World Academy Biomedical Technologies, UNESCO, and Adjunct Professor Department Biology Temple University College of Science and Techology, Philadelphia. Recipient of the Sbarro Health Research Organization lifetime achievement award (2010). His researches have been concerned with the characterization of specific virus-induced tumor antigens, which were the “finger-prints” left behind in human cancer. Achievements include patents in field; discovery of Respiratory Syncytial Virus in infant deaths in Naples and of tumor liberated protein as a tumor associated antigen, 55 kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas. President Foundation de Beaumont Bonelli for Cancer Research.

Murine Virology, Antiviral Chemotherapy, Effects of inhibitors on viraI replication, Studies on the role of herpesviruses in cancer, Tumor Immunology Pathology of AIDS